American pharmaceutical company Pfizer has recalled batches of its Xalatan 0.005%w/v eye drops solution in Nigeria.
The solution is used in treating glaucoma.
According to an online medium, a notice of the recall was sent to doctors.
The notice partly read, “Please be advised that Pfizer is recalling, at the patient level, the below lots of Xalatan 0.005%w/v Eye drops solution (the “Product Lots”) from distribution in Nigeria.
“The use of the counterfeit Product Lots has a high probability to cause therapeutic failure and adverse events, such as infections. The potential risk to patients is considered high as patients will not be able to identify the counterfeit product.”
The product batches affected are those with lot numbers W67369; expiring 10/2020 and AK4753 expiring 10/2021.
